Veristat, in partnership with TOPRA, recently hosted an insightful webinar titled "Future Trends on European Regulations on Medicines." This webinar provided valuable updates on the new Pharmaceutical Strategy for Europe and its impact on the regulatory landscape. If you missed the live session, don't worry! You can still benefit from the valuable insights shared by our experts.
What You Will Learn: The European Commission's adoption of the new Pharmaceutical Strategy for Europe aims to ensure accessibility, affordability, and innovation in the pharmaceutical industry. During this webinar, our regulatory experts discussed the four main pillars of the strategy, including addressing unmet medical needs, promoting competitiveness and sustainability, ensuring a secure supply chain, and strengthening the EU's global voice. Additionally, we explored the upcoming revisions to the Orphan Regulation and Pediatric Regulation, shedding light on the expected changes.
Understanding the impact of the new Pharmaceutical Strategy on patient access to medicines and addressing unmet medical needs.
Gaining insights into the competitive and innovative landscape of the European pharma industry.
Exploring the importance of diversifying and securing the pharmaceutical supply chain for enhanced resilience.
Recognizing the significance of an effective EU voice in the global regulatory landscape.
Meet the Speakers:
The webinar featured industry experts who shared their extensive knowledge and experience in regulatory affairs.
With a decade of regulatory consulting experience and a background in internal medicine and pharmaceutical medicine, Dr. Luria is an authority on global regulatory and pharmacovigilance services. His expertise ensures effective communication with health authorities and the development of robust regulatory documentation.
Michael Paul, Associate Director, European Regulatory Affairs, Veristat
Michael brings 15 years of experience in regulatory affairs, specializing in early-stage development to late-phase projects. His expertise covers many regulatory procedures, including scientific advice, pediatric investigations, and regulatory strategy.
Paula Meler, Associate Manager, European Regulatory Affairs, Veristat
Paula's proficiency lies in managing Marketing Authorisation Applications, Orphan Drug Designations, and regulatory strategic analysis. With a strong background in biomedical science and biomedicine, she offers valuable insights into the development of medicinal products.
Don't Miss Out:
If you couldn't attend the live webinar, you still can benefit from the valuable information shared by our experts. You can download the on-demand webinar or access the slide presentation to understand the European regulatory landscape comprehensively.
Stay informed, gain a competitive edge, and navigate the evolving European regulations with Veristat and TOPRA.